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No good ending can be expected in the absence of the 
right beginning.
—I Ching
Mitral valve prolapse (MVP) is the most frequent cause of primary mitral regurgitation in western countries.1 The 
diagnosis can be suspected from cardiac auscultation in some 
cases but is mostly confirmed by echocardiography. MVP has 
been for long suspected of being more than a benign disease.2,3 
Nonspecific symptoms and major consequences, such as 
symptomatic severe mitral regurgitation, infective endocardi-
tis, and cerebrovascular accidents, have been reported as non-
arrhythmic complications of MVP.4 In some patients, atrial or 
ventricular arrhythmias can occur as serious clinical manifes-
tations even in the absence of significant mitral regurgitation 
or hemodynamic compromise.3 Though still controversial, 
arrhythmic MVP patients are likely at increased risk of sudden 
cardiac death as compared with either nonarrhythmic MVP 
patients or the general population. Prior cardiac arrest and sus-
tained ventricular tachycardia are strong predictors of sudden 
cardiac death in patients with MVP.5 Other features, such as 
electrocardiographic abnormalities (QT interval prolongation, 
repolarization abnormalities), flail mitral leaflet, significant 
mitral regurgitation, left ventricular (LV) dysfunction, or the 
presence of ventricular fibrosis, have also been highlighted 
as potential predictors of sudden cardiac death.6–8 Although 
the propensity of MVP to cause sudden cardiac death has 
been extensively discussed because of the high prevalence 
of MVP in the general population, no specific recommenda-
tions for risk stratification of patients with MVP have been 
defined in the current European and American guidelines.9,10 
Refining risk factors and identifying mechanisms causing/
associated with malignant arrhythmias are of paramount clini-
cal significance.
See Article by Perazzolo Marra et al
Ventricular arrhythmic MVP seems to be characterized 
by LV fibrosis and myxomatous disease.3 With the aim to 
identify features related with stretch-induced scar/fibrosis 
and arrhythmic MVP, Perazzolo Marra et al,11 in this issue of 
Circulation: Cardiovascular Imaging, performed a morpho-
logical assessment of the mitral valve with a particular focus 
on mitral annular disjunction (MAD). They studied 2 distinct 
populations: patients with arrhythmia and cases of sudden 
death. Direct observation and measurements on a magnified 
image were used for assessment of the pathology specimens, 
whereas cardiac magnetic resonance (CMR) was used in the 
clinical study, both for detection of myocardial fibrosis and 
for morphological assessment. They also examined the cor-
relation of auscultative and clinical findings to develop a com-
prehensive predictive scenario for identifying high-risk MVP 
patients with serious arrhythmias.
A total of 36 (median age 44 years) arrhythmic MVP 
patients with LV late gadolinium enhancement (LGE) on 
CMR and no or trivial mitral regurgitation and 16 (median age 
40 years) MVP patients without LGE (control group) were 
evaluated. Complex ventricular arrhythmias consisted of ven-
tricular fibrillation and sustained or nonsustained ventricular 
tachycardia. The pathology arm of the study included sudden 
cardiac death victims with MVP and LV fibrosis and hearts 
from sex- and age-matched patients who died suddenly as a 
result of extracardiac causes as controls.1 MAD, mitral annu-
lus diameter, posterior systolic curling, and the lengths of the 
mitral valve leaflets were the morpho-functional parameters 
assessed. The real amplitude of mitral valve leaflet excursion 
into the left atrium, the presence of leaflet eversion into the left 
atrium, and the area of the leaflets were not described.
MAD was described in 1986 by Hutchins et al based on 
pathology assessment of 900 hearts, only 25 of which had 
MVP.12 MAD was defined as separation between the junction 
of the left atrial wall with the mitral valve leaflet and the junc-
tion of the left atrial wall with the myocardium of the LV. In 
other words, MAD comprises a spatial displacement of the 
point of insertion of the mitral valve leaflet in the left atrial 
wall away from the myocardium. Being found in ≈6% of the 
hearts, MAD was considered to be an anatomic variation of 
mitral annulus morphology. However, the incidence of MAD 
was found to be higher in MVP (23 out of the 25 cases), lead-
ing to the conclusion that MAD is specifically associated with 
MVP. Furthermore, the relatively younger age (60±2 years old 
versus 68±3 years old) of the 42 cases with MAD but without 
MVP led to the hypothesis that MAD could be incriminated 
for the later development of myxomatous degeneration and 
prolapse of the mitral valve leaflets. The significance given to 
MAD by Hutchins et al and their interpretation of the results 
were questioned at the time by a series of pathology experts 
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who argued that MAD is only an anatomic variation of mitral 
annulus morphology present in the general population in a 
certain proportion of the annular circumference, rather than 
a feature specifically associated with MVP and the develop-
ment of it.13
The prevalence of MAD in patients with MVP and its 
implications remained, thus, unknown. Carmo et al,14 using 
2D echocardiography, reported a prevalence of 55% of MAD 
(7.4±8.7 mm) in the setting of myxomatous mitral valve dis-
ease. In their study, Perazzolo Marra et al had lower CMR 
MAD values, which also differed from those obtained on 
pathology specimens.11 Median CMR–measured MAD length 
was 4.8 mm in MVP patients with myocardial fibrosis and 
1.8 mm in MVP patients without myocardial fibrosis. Median 
pathology–measured MAD length was 3 mm in sudden death 
cases with MVP and 1.5 mm in sudden death cases without 
MVP. These median pathology–measured MAD length values 
also differ remarkably from the transoesophageal echocar-
diography–measured values in the surgical study of Eriksson 
et al.15 In this study, the mean MAD value was 10±3 mm in 
patients with severe degenerative mitral valve disease and 
8.2±4.7 mm in patients with mild to moderate degenerative 
mitral valve disease. This wide range of obtained MAD length 
values might be explained by inherent variations related to the 
measurement method used, technical imaging considerations 
(limited spatial and temporal resolution), difficulty in defin-
ing the margins of MAD (separation between the left atrial 
wall–mitral valve junction and the top of the LV wall), and 
different patient population analyzed. For instance, during 
pathology assessment (direct observation of specimens) or 
surgical inspection, the heart dimensions appear maximized, 
corresponding more to diastolic rather than systolic dimen-
sions in the beating heart as obtained on echocardiographic or 
CMR imaging. All this means that MAD values obtained by 
different methodologies and techniques are not interchange-
able and should be compared and interpreted with caution.
Carmo et al14 were the first to show an association 
between MAD and the presence of chest pain, mitral annulus 
dysfunction (paradoxical systolic increase of the mitral annu-
lus diameter), an increased frequency of premature ventricu-
lar beats, and nonsustained ventricular arrhythmias in patients 
with MVP and different degrees of mitral regurgitation. The 
wider the magnitude of the MAD, the higher was the inci-
dence of nonsustained ventricular arrhythmias. A disjunction 
>8.5 mm predicted nonsustained ventricular arrhythmias with 
a sensitivity of 67% and a specificity of 83%. In their study, 
Perazzolo Marra et al11 confirmed and extended these obser-
vations. In fact, MAD was a common feature in arrhythmic 
MVP patients with LV LGE CMR (36/52, 69%) and in sudden 
cardiac death cases with LV fibrosis. No specific MAD thresh-
old was provided to discriminate arrhythmic MVP patients.
Malignant MVP likely represents a specific entity, most 
often observed in young adult women with a midsystolic click 
on auscultation, bileaflet mitral valve involvement, repolariza-
tion abnormalities in the inferior ECG leads, RBBB-type or 
polymorphic ventricular arrhythmias, and no or trivial mitral 
regurgitation on echocardiography.3–7 The mechanisms of 
ventricular arrhythmias in these MVP patients remain specu-
lative. Extravalvular factors (autonomic nervous system dys-
function, conduction system abnormalities, fibromuscular 
dysplasia of small coronary arteries, and occult cardiomy-
opathies), MVP-related features (excessive papillary muscles 
traction by the prolapsing leaflets, mechanical stimulation of 
the endocardium by the elongated chordae, diastolic depolar-
ization of muscle fibers in redundant leaflets with triggered 
repetitive automaticity), ventricular substrates (LV fibrosis 
at the level of papillary muscles and basal postero-lateral 
wall), and mitral valve structural abnormalities (mitral annu-
lus dilatation, elongated mitral leaflet) have been advocated 
(Figure).3,16–20 Unexpectedly, no study assessed the morpho-
functional abnormalities of the mitral valve complex as poten-
tial promoters of regional ventricular remodeling/alterations.
As previously reported in their first study,3 Perazzolo 
Marra et al11 showed that LV fibrosis was mostly located 
close to the annulus in the basal LV wall (papillary muscles 
and infero-basal free wall). In the arrhythmic MVP patients, 
Figure.  Mechanisms of ventricular arrhythmias 
in mitral valve prolapse (MVP) patients with pre-
served left ventricular (LV) ejection fraction and no 
or trivial mitral regurgitation.
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a relative hypertrophy of inferobasal wall compared with 
the adjacent mid portion was also found. Additionally, the 
authors identified that posterior systolic curling of the mitral 
annulus was associated linearly with MAD and accounts for 
annular hypermobility. Mid-mural LGE in the LV inferobasal 
wall was demonstrated in 72% of cases, all having MAD and 
curling. A positive linear correlation was observed between 
the length of MAD and the extent of fibrosis (LGE CMR). 
Interestingly, MAD was longer in bileaflet than in single leaf-
let MVP patients. The prevalence of curling and LGE was also 
higher in bileaflet MVP. On auscultation, 32 MVP patients 
had a midsystolic click. Patients with midsystolic click had 
longer MAD, curling, LGE on CMR, and complex ventricu-
lar arrhythmias as compared with those without a click. This 
auscultatory click was likely because of the tension produced 
on the mitral valve apparatus by the abnormal posterior leaf-
let systolic curling. So, the altered mechanical stresses that 
this unique annular morphology/hypermobility results in may 
cause stress-induced LV infero-basal lesions (hypertrophy/
scar) that could be clinically suggested by auscultatory mid-
systolic click. Therefore, MAD, curling, and mitral annular 
abnormal contractility are associated with arrhythmic MVP, 
whereas the absence of these features seems to imply a low 
risk. However, although the abovementioned morpho-func-
tional abnormalities could be potential substrates for ven-
tricular remodeling and consequent electric instability, their 
association with malignant arrhythmias and sudden cardiac 
death require further confirmation. Also, whether the pres-
ence of these mitral valve anomalies in MVP patients without 
arrhythmia might predict future mitral valve disease progres-
sion and development of complex ventricular arrhythmia is 
unknown. Efforts to describe morphological features associ-
ated with arrhythmia with the aim to identify candidates for 




 1. Delling FN, Vasan RS. Epidemiology and pathophysiology of mi-
tral valve prolapse: new insights into disease progression, genetics, 
and molecular basis. Circulation. 2014;129:2158–2170. doi: 10.1161/
CIRCULATIONAHA.113.006702.
 2. Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman 
B, Benjamin EJ. Prevalence and clinical outcome of mitral-valve prolapse. 
N Engl J Med. 1999;341:1–7. doi: 10.1056/NEJM199907013410101.
 3. Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani 
A, Frigo AC, Rigato I, Migliore F, Pilichou K, Bertaglia E, Cacciavillani 
L, Bauce B, Corrado D, Thiene G, Iliceto S. Arrhythmic mitral valve 
prolapse and sudden cardiac death. Circulation. 2015;132:556–566. doi: 
10.1161/CIRCULATIONAHA.115.016291.
 4. Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, 
Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier 
A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst 
R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunemaitre 
XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, 
Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat 
M, Rosenthal N, Solis J, Schott JJ, Schwammenthal E, Slaugenhaupt SA, 
Song JK, Yacoub MH; Leducq Mitral Transatlantic Network. Mitral valve 
disease–morphology and mechanisms. Nat Rev Cardiol. 2015;12:689–
710. doi: 10.1038/nrcardio.2015.161.
 5. Vohra J, Sathe S, Warren R, Tatoulis J, Hunt D. Malignant ventricular ar-
rhythmias in patients with mitral valve prolapse and mild mitral regurgita-
tion. Pacing Clin Electrophysiol. 1993;16(3 pt 1):387–393.
 6. Narayanan K, Uy-Evanado A, Teodorescu C, Reinier K, Nichols GA, 
Gunson K, Jui J, Chugh SS. Mitral valve prolapse and sudden cardiac 
arrest in the community. Heart Rhythm. 2016;13:498–503. doi: 10.1016/j.
hrthm.2015.09.026.
 7. Missov E, Cogswell R. Sudden cardiac death, mitral valve prolapse, 
and long QT syndrome. Am J Med. 2015;128:e37–e38. doi: 10.1016/j.
amjmed.2015.05.030.
 8. Digeos-Hasnier S, Copie X, Paziaud O, Abergel E, Guize L, Diebold 
B, Jeunemaître X, Berrebi A, Piot O, Lavergne T, Le Heuzey JY. 
Abnormalities of ventricular repolarization in mitral valve pro-
lapse. Ann Noninvasive Electrocardiol. 2005;10:297–304. doi: 
10.1111/j.1542-474X.2005.00630.x.
 9. Priori SG, Blomström-Lundqvist C. 2015 European Society of Cardiology 
Guidelines for the management of patients with ventricular arrhythmias 
and the prevention of sudden cardiac death summarized by co-chairs. Eur 
Heart J. 2015;36:2757–2759. doi: 10.1093/eurheartj/ehv445.
 10. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer 
M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones 
MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams 
CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, 
Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, 
Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, 
Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/
ESC 2006 guidelines for management of patients with ventricular ar-
rhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol. 
2006;48:e247–e346.
 11. Perazzolo Marra M, Basso C, De Lazzari M, Rizzo S, Cipriani A, 
Giorgi B, Lacognata C, Rigato I, Migliore F, Pilichou K, Cacciavillani 
L, Bertaglia E, Frigo AC, Bauce B, Corrado D, Thiene G, Iliceto S. 
Morphofunctional abnormalities of mitral annulus and arrhythmic mitral 
valve prolapse. Circ Cardiovasc Imaging. 2016;9:e005030. doi: 10.1161/
CIRCIMAGING.116.005030.
 12. Hutchins GM, Moore GW, Skoog DK. The association of floppy mitral 
valve with disjunction of the mitral annulus fibrosus. N Engl J Med. 
1986;314:535–540. doi: 10.1056/NEJM198602273140902.
 13. Angelini A, Ho SY, Anderson RH, Becker AE, Davies MJ. Disjunction of 
the mitral annulus in floppy mitral valve. N Engl J Med. 1988;318:188–
189. doi: 10.1056/NEJM198801213180315.
 14. Carmo P, Andrade MJ, Aguiar C, Rodrigues R, Gouveia R, Silva JA. 
Mitral annular disjunction in myxomatous mitral valve disease: a relevant 
abnormality recognizable by transthoracic echocardiography. Cardiovasc 
Ultrasound. 2010;8:53. doi: 10.1186/1476-7120-8-53.
 15. Eriksson MJ, Bitkover CY, Omran AS, David TE, Ivanov J, Ali MJ, Woo 
A, Siu SC, Rakowski H. Mitral annular disjunction in advanced myxo-
matous mitral valve disease: echocardiographic detection and surgical 
correction. J Am Soc Echocardiogr. 2005;18:1014–1022. doi: 10.1016/j.
echo.2005.06.013.
 16. Salazar AE, Edwards JE. Friction lesions of ventricular endocar-
dium. Relation to chordae tendineae of mitral valve. Arch Pathol. 
1970;90:364–376.
 17. Mason JW, Koch FH, Billingham ME, Winkle RA. Cardiac biopsy evi-
dence for a cardiomyopathy associated with symptomatic mitral valve 
prolapse. Am J Cardiol. 1978;42:557–562.
 18. Boudoulas H, Kolibash AJ Jr, Baker P, King BD, Wooley CF. Mitral valve 
prolapse and the mitral valve prolapse syndrome: a diagnostic classifica-
tion and pathogenesis of symptoms. Am Heart J. 1989;118:796–818.
 19. Burke AP, Farb A, Tang A, Smialek J, Virmani R. Fibromuscular dysplasia 
of small coronary arteries and fibrosis in the basilar ventricular septum in 
mitral valve prolapse. Am Heart J. 1997;134(2 pt 1):282–291.
 20. Bharati S, Granston AS, Liebson PR, Loeb HS, Rosen KM, Lev M. The 
conduction system in mitral valve prolapse syndrome with sudden death. 
Am Heart J. 1981;101:667–670.
KEY WORDS: Editorials ◼ arrhythmia ◼ Barlow’s disease ◼ magnetic 
resonance imaging ◼ mitral valve ◼ ventricular arrhythmias
 by guest on August 12, 2016http://circimaging.ahajournals.org/Downloaded from 
Patrizio Lancellotti and Madalina Garbi
Malignant Mitral Valve Prolapse: Substrates to Ventricular Remodeling and Arrhythmias
Print ISSN: 1941-9651. Online ISSN: 1942-0080 
Copyright © 2016 American Heart Association, Inc. All rights reserved.
Dallas, TX 75231
is published by the American Heart Association, 7272 Greenville Avenue,Circulation: Cardiovascular Imaging 
doi: 10.1161/CIRCIMAGING.116.005248
2016;9:e005248Circ Cardiovasc Imaging. 
 http://circimaging.ahajournals.org/content/9/8/e005248
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
  
 http://circimaging.ahajournals.org//subscriptions/
is online at: Circulation: Cardiovascular Imaging  Information about subscribing to Subscriptions:
  
 http://www.lww.com/reprints
 Information about reprints can be found online at: Reprints:
  
document. Permissions and Rights Question and Answer information about this process is available in the
requested is located, click Request Permissions in the middle column of the Web page under Services. Further
Center, not the Editorial Office. Once the online version of the published article for which permission is being 
 can be obtained via RightsLink, a service of the Copyright ClearanceCirculation: Cardiovascular Imagingin
 Requests for permissions to reproduce figures, tables, or portions of articles originally publishedPermissions:
 by guest on August 12, 2016http://circimaging.ahajournals.org/Downloaded from 
